EP3470063
LYFJASAMSETNINGAR FYRIR MEÐHÖNDUN Á CFTR-MIÐLUÐUM SJÚKDÓMUM
:
EP einkaleyfi í gildi á Íslandi:
1.11.2013:
1.1.2025:
18192504.1
:
19.2.2025:
15.3.2025
:
31.10.2033:
31.10.2025
:
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES
1.11.2013
1.1.2025
19.2.2025
15.3.2025
31.10.2025
:
Vertex Pharmaceuticals Incorporated:
50 Northern Avenue, Boston, MA 02210, US
:
VERWIJS, Marinus, Jacobus:
Framingham, Massachusetts 01701, US
:
KARKARE, Radhika:
Framingham, Massachusetts 01701, US
:
MOORE, Michael, Douglas:
Charlestown, Massachusetts 02129, US
:
Zacco Denmark A/S:
Arne Jacobsens Allé 15, DK
:
201261721622 P:
2.11.2012:
US
:
201261728328 P:
20.11.2012:
US
:
201361770668 P:
28.2.2013:
US
:
201361824005 P:
16.5.2013:
US
:
201361840668 P:
28.6.2013:
US
:
A61P 11/00, A61K 9/20, A61K 45/06, A61K 31/443, A61K 31/47